![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 26, 2021 11:23:15 AM
The reality is that this is just a question of whether McNally can execute, whether the technology has any commercial promise if it obtains its clearances, and if the company has any viable exit to an acquirer, MDT or otherwise.
The stock price remains where it is as those are the fundamental questions that remain outstanding, no proof yet that the Enos system brings something new to the market and that there's value in the IP beyond what MDT and others are already developing themselves. The company's own actions send signals of no imminent commercialization efforts (just look at the hiring page and how old the recs are and how few positions are posted).
These questions aren't answered by any incremental patent approval or McNally saying that he completed procedures on pigs and now facing delays due to the pathology testing, etc.
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM